-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the evening of June 22, China’s National Food and Drug Administration (NMPA) recently announced that Haosen Pharmaceutical’s Class 1 new drug imitenofovir tablets (also known as eimofolamine tenofovir tablets) has officially been approved in China.
According NMPA Center for Drug Evaluation (CDE) priority reviews publicity, presumably for the application of indications: for the treatment of adult patients with chronic hepatitis
Screenshot source: NMPA official website